PARATHYROID HORMONE (PTH) A new class of osteoporosis treatments called bone formation agents Parathyroid hormone analogues belong to a class of osteoporosis medications which can promote bone growth. In Canada, […]

Board of Directors Jeannette Briggs Chair | Oakville, ON Jeannette has more than 25 years of experience working in the energy sector.  She has held a wide-range of jobs within […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

GET SUPPORT Support Resources Osteoporosis Canada currently produces publications in various languages. LEARN MORE Let’s Talk The information line gives you access to trained and compassionate staff and volunteers who […]

Bone Health & Osteoporosis Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue, which can lead to increased risk of fracture. Nutrition and exercise can […]

Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]

Healthcare Providers Guideline and Recommendations Find information and links to the 2023 Clinical Practice Guideline and Exercise and Long-Term Care Recommendations. Learn about Osteoporosis Canada’s Scientific Advisory Council (SAC). VIEW […]

Cook with OC Cook with OC Osteoporosis Canada is providing strategies, new ideas and recipes to help you get the bone building nutrients needed for bone health. Nutrition is a […]

About Us Educate, empower and support Who Are We Osteoporosis Canada is the only national organization serving people affected by osteoporosis. The organization works to educate, empower and support individuals […]